TM6SF2 and metabolic dysfunction-associated steatotic liver disease: The transmembrane 6 superfamily member 2 (TM6SF2) E167K gene variant, interfering with VLDL secretion, which may be stimulated in early NAFLD [10], has recently been shown to increase susceptibility to progressive NASH by compartmentalization of lipids within hepatocytes [11, 12].